Skip to main content
American Journal of Public Health logoLink to American Journal of Public Health
. 1989 Nov;79(11):1544–1548. doi: 10.2105/ajph.79.11.1544

To tell or not to tell: the ethical dilemmas of HIV test notification in epidemiologic research.

A L Avins 1, B Lo 1
PMCID: PMC1349811  PMID: 2817169

Abstract

Epidemiologic studies involving HIV (human immunodeficiency virus) antibody testing create ethical dilemmas, particularly about notifying asymptomatic seropositive subjects. Four study designs address this problem: mandatory notification, optional notification, anonymous testing, and blind testing. No single design consistently optimizes the trade-off between valid and ethical research. Each strategy differs substantially from the others in its effect on response rates, bias, ability to perform longitudinal studies, numbers of subjects who learn their test results, and the number of subjects counseled about HIV risk reduction. Both local institutional review boards and potential subjects of study (and their sexual partners) should participate in decisions regarding the conduct of sensitive AIDS (acquired immunodeficiency syndrome) research.

Full text

PDF
1545

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen J. R., Curran J. W. Prevention of AIDS and HIV infection: needs and priorities for epidemiologic research. Am J Public Health. 1988 Apr;78(4):381–386. doi: 10.2105/ajph.78.4.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bayer R., Levine C., Wolf S. M. HIV antibody screening. An ethical framework for evaluating proposed programs. JAMA. 1986 Oct 3;256(13):1768–1774. doi: 10.1001/jama.256.13.1768. [DOI] [PubMed] [Google Scholar]
  3. Bayer Ronald, Levine Carol, Murray Thomas H. Guidelines for confidentiality in research on AIDS. IRB. 1984 Nov-Dec;6(6):1–7. [PubMed] [Google Scholar]
  4. Belongia E. A., Golubjatnikov R., McClellan-Tilson B., Wiesen R. L., Vergeront J. M., Davis J. P. Human immunodeficiency virus seroprevalence and drug-using behavior in Milwaukee intravenous drug abusers. J Acquir Immune Defic Syndr. 1988;1(4):381–385. [PubMed] [Google Scholar]
  5. Blendon R. J., Donelan K. Discrimination against people with AIDS: the public's perspective. N Engl J Med. 1988 Oct 13;319(15):1022–1026. doi: 10.1056/NEJM198810133191522. [DOI] [PubMed] [Google Scholar]
  6. Booth W. A frustrating glimpse of the true AIDS epidemic. Science. 1987 Nov 6;238(4828):747–747. doi: 10.1126/science.2823386. [DOI] [PubMed] [Google Scholar]
  7. Brennan T. A. AIDS and the limits of confidentiality: the physician's duty to warn contacts of seropositive individuals. J Gen Intern Med. 1989 May-Jun;4(3):242–246. doi: 10.1007/BF02599532. [DOI] [PubMed] [Google Scholar]
  8. Coates T. J., Morin S. F., McKusick L. Behavioral consequences of AIDS antibody testing among gay men. JAMA. 1987 Oct 9;258(14):1889–1889. [PubMed] [Google Scholar]
  9. Coates T. J., Stall R. D., Kegeles S. M., Lo B., Morin S. F., McKusick L. AIDS antibody testing. Will it stop the AIDS epidemic? Will it help people infected with HIV? Am Psychol. 1988 Nov;43(11):859–864. [PubMed] [Google Scholar]
  10. Curran J. W., Jaffe H. W., Hardy A. M., Morgan W. M., Selik R. M., Dondero T. J. Epidemiology of HIV infection and AIDS in the United States. Science. 1988 Feb 5;239(4840):610–616. doi: 10.1126/science.3340847. [DOI] [PubMed] [Google Scholar]
  11. Frierson R. L., Lippmann S. B. Suicide and AIDS. Psychosomatics. 1988 Spring;29(2):226–231. doi: 10.1016/S0033-3182(88)72403-2. [DOI] [PubMed] [Google Scholar]
  12. Glass R. M. AIDS and suicide. JAMA. 1988 Mar 4;259(9):1369–1370. [PubMed] [Google Scholar]
  13. Gostin L. O. Public health strategies for confronting AIDS. Legislative and regulatory policy in the United States. JAMA. 1989 Mar 17;261(11):1621–1630. [PubMed] [Google Scholar]
  14. Gostin L., Curran W. J. AIDS screening, confidentiality, and the duty to warn. Am J Public Health. 1987 Mar;77(3):361–365. doi: 10.2105/ajph.77.3.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gray Joni N., Melton Gary B. The law and ethics of psychosocial research on AIDS. Neb Law Rev. 1985;64(4):637–688. [PubMed] [Google Scholar]
  16. Grimshaw J. ABC of AIDS. Being HIV antibody positive. Br Med J (Clin Res Ed) 1987 Jul 25;295(6592):256–257. doi: 10.1136/bmj.295.6592.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kaslow R. A., Ostrow D. G., Detels R., Phair J. P., Polk B. F., Rinaldo C. R., Jr The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol. 1987 Aug;126(2):310–318. doi: 10.1093/aje/126.2.310. [DOI] [PubMed] [Google Scholar]
  18. Kelen G. D., Fritz S., Qaqish B., Brookmeyer R., Baker J. L., Kline R. L., Cuddy R. M., Goessel T. K., Floccare D., Williams K. A. Unrecognized human immunodeficiency virus infection in emergency department patients. N Engl J Med. 1988 Jun 23;318(25):1645–1650. doi: 10.1056/NEJM198806233182503. [DOI] [PubMed] [Google Scholar]
  19. Levy N., Carlson J. R., Hinrichs S., Lerche N., Schenker M., Gardner M. B. The prevalence of HTLV-III/LAV antibodies among intravenous drug users attending treatment programs in California: a preliminary report. N Engl J Med. 1986 Feb 13;314(7):446–446. doi: 10.1056/NEJM198602133140711. [DOI] [PubMed] [Google Scholar]
  20. Lyter D. W., Valdiserri R. O., Kingsley L. A., Amoroso W. P., Rinaldo C. R., Jr The HIV antibody test: why gay and bisexual men want or do not want to know their results. Public Health Rep. 1987 Sep-Oct;102(5):468–474. [PMC free article] [PubMed] [Google Scholar]
  21. McCusker J., Stoddard A. M., Mayer K. H., Zapka J., Morrison C., Saltzman S. P. Effects of HIV antibody test knowledge on subsequent sexual behaviors in a cohort of homosexually active men. Am J Public Health. 1988 Apr;78(4):462–467. doi: 10.2105/ajph.78.4.462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Melton G. B., Gray J. N. Ethical dilemmas in AIDS research. Individual privacy and public health. Am Psychol. 1988 Jan;43(1):60–64. doi: 10.1037//0003-066x.43.1.60. [DOI] [PubMed] [Google Scholar]
  23. Novick L. F., Berns D., Stricof R., Stevens R., Pass K., Wethers J. HIV seroprevalence in newborns in New York State. JAMA. 1989 Mar 24;261(12):1745–1750. [PubMed] [Google Scholar]
  24. Quinn T. C., Glasser D., Cannon R. O., Matuszak D. L., Dunning R. W., Kline R. L., Campbell C. H., Israel E., Fauci A. S., Hook E. W., 3rd Human immunodeficiency virus infection among patients attending clinics for sexually transmitted diseases. N Engl J Med. 1988 Jan 28;318(4):197–203. doi: 10.1056/NEJM198801283180401. [DOI] [PubMed] [Google Scholar]
  25. Sherer R. Physician use of the HIV antibody test. The need for consent, counseling, confidentiality, and caution. JAMA. 1988 Jan 8;259(2):264–265. [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES